Biotech industry growth is bolstered by increased R&D spending, an upswing of approved first-in-class medicines, elevated Wall Street valuations, and continued forging of pipeline alliances with Big Pharma. By Andrew Humphreys (andrew.humphreys@ubm. …
(Thomson Reuters ONE via COMTEX) -- Medigene AG / Medigene's drug Veregen� receives market authorization notification in Taiwan . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. …
CTI Clinical Trial and Consulting Services Announces the Formation of Polish Subsidiary and Opens Office in Warsaw [Cincinnati, OH ~ May 13, 2013] CTI Clinical Trial and Consulting Services (CTI) announces that it has opened an office in Warsaw, Poland …
LONDON: Irish biotechnology company Elan announced a series of deals yesterday to boost growth, in the face of a $6bn hostile takeover approach by US group Royalty Pharma. “Elan Corporation plc today announces a series of transactions designed to …
pSivida (PSDV) is a leading provider of miniaturized, sustained-release drug delivery products, and is continuing the evolution of these systems. The company has developed three of only four products approved by either the U.S. or EU for long-term, …
LOS ANGELES – The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc and AstraZeneca have grown dependent on higher U.S. prices to …
NEW YORK, April 30, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Ophthalmic Drugs: World Market Prospects 2013-2023 http://www.reportlinker.com/p0847305/ …
Lundbeck has launched its alcoholism treatment Selincro in its first markets - Norway, Finland, Poland and the Baltic countries. Selincro (nalmefene) was approved at the end of February and is the first new treatment for alcohol dependence in Europe for …
Published: April 22, 2013 Press Release SALISBURY, England, April 22, 2013 /PRNewswire/ -- NanoSight, leading manufacturers of unique nanoparticle characterization technology, are pleased to announce that the company has been selected to receive the Queen …
JERUSALEM, April 18, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral delivery systems, announced today that its abstract, titled "Oral insulin may be effective in lowering hepatic insulin …
Thesis Early detection of chronic diseases has been a growing trend within the healthcare sector, and it's easy to see why. The benefits are obvious. If diseases such as cancer and heart disease are diagnosed in their early stages, not only are they …
LOCKPORT – A lawsuit filed here last week pits a Hungarian discus thrower, who was barred from last summer’s Olympic Games in London because of a failed drug test, against a Canadian company that he claims concealed the presence of steroids in a protein …
IBM announced that an IBM Blue Gene/Q supercomputer known as "Nostromo" is being used to process biomedical big data in Poland. IBM announced that The Interdisciplinary Centre for Mathematical and Computational Modeling, University of Warsaw ( …
WARSAW, Poland, April 4, 2013 /PRNewswire/ -- IBM (NYSE: IBM) Blue Gene/Q, the most powerful single architecture supercomputer in Poland, has been chosen by The Interdisciplinary Centre for Mathematical and Computational Modeling, University of Warsaw ( …
Published: April 04, 2013 Press Release WARSAW, Poland, April 4, 2013 /PRNewswire/ -- IBM (NYSE: IBM) Blue Gene/Q, the most powerful single architecture supercomputer in Poland, has been chosen by The Interdisciplinary Centre for Mathematical and …
The Hungarian pharmaceutical market reportedly declined by 3.67% year-on-year in 2012, although the hospital sector enjoyed impressive value growth. IHS Global Insight perspective Significance In 2012, the Hungarian pharmaceutical market fell in value …
The European Medicines Agency recently awarded the Austrian biotech company Activartis an Orphan Drug Designation for its innovative Cancer Immune Therapy AV0113. The Orphan Drug Designation applies specifically to the use of AV0113 for the treatment of …
WATERTOWN, Mass.--(BUSINESS WIRE)--Mar 20, 2013 - pSivida Corp. (NASDAQ:PSDV; ASX:PVA), a specialty pharmaceutical company that is a leader in the development of sustained release ophthalmic drug treatments, today announced that the Company's Vice …
Feb. 28 (Bloomberg) -- Mylan Inc.’s $1.6 billion agreement to buy Strides Arcolab Ltd.’s injectable-medicine unit will help the U.S. company’s push into copies of expensive biotechnology drugs, Chief Executive Officer Heather Bresch said. “Injectables …
A new payment-by-results system is set to be introduced for high-cost biotech drugs used in oncology and other therapeutic areas in Hungary. IHS Global Insight perspective Significance The Hungarian State Secretariat for Healthcare has revealed details …
For more than 15 years, EIN News' services have influenced analysis and decisions of executives. We have provided content to websites & blogs, and are a platform for news distribution. Get a membership today and receive:
About EIN News: Since 1995, EIN News has served thousands of business, industry, academic and government customers from organizations such as CNN, World Bank, EU, ExxonMobil, Daimler Chrysler and many more. It is published by the Washington, DC-based IPD Group, a provider of media monitoring and press release services.
Get your message out, reach 7 million viewers, including leading journalists, decision makers and industry professionals, and improve your search engine rankings.
- Compare packages
Get professional-quality news delivered to your site 24 hours a day. We give you up-to-the-minute news on any topic of your choice. Many output formats to choose from.
- Get started
Post announcements for your meetings, conferences, trade fairs, or other industry events. Your events will be shown to the people you want to reach.
- Add a listing
EIN News covers all countries in the world as well as hundreds of topics ranging from politics, business, industry to society & culture. Read news online, by email or via RSS.
- View the list of news publications
